W.H. Wilson Tang

107.1k total citations · 27 hit papers
978 papers, 50.2k citations indexed

About

W.H. Wilson Tang is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, W.H. Wilson Tang has authored 978 papers receiving a total of 50.2k indexed citations (citations by other indexed papers that have themselves been cited), including 616 papers in Cardiology and Cardiovascular Medicine, 187 papers in Molecular Biology and 159 papers in Pulmonary and Respiratory Medicine. Recurrent topics in W.H. Wilson Tang's work include Heart Failure Treatment and Management (352 papers), Cardiovascular Function and Risk Factors (214 papers) and Cardiac pacing and defibrillation studies (105 papers). W.H. Wilson Tang is often cited by papers focused on Heart Failure Treatment and Management (352 papers), Cardiovascular Function and Risk Factors (214 papers) and Cardiac pacing and defibrillation studies (105 papers). W.H. Wilson Tang collaborates with scholars based in United States, Belgium and United Kingdom. W.H. Wilson Tang's co-authors include Stanley L. Hazen, Alfredo H.‐S. Ang, Yuping Wu, Zeneng Wang, Wilfried Müllens, Bruce S. Levison, Xiaoming Fu, Robert Koeth, Gary S. Francis and Earl B. Britt and has published in prestigious journals such as Nature, New England Journal of Medicine and Cell.

In The Last Decade

W.H. Wilson Tang

910 papers receiving 48.9k citations

Hit Papers

Gut flora metabolism of p... 1975 2026 1992 2009 2011 2013 1975 2016 2017 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
    2011 4.1k citations W.H. Wilson Tang et al. profile →
  2. Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk
    2013 2.4k citations W.H. Wilson Tang et al. profile →
  3. Probability Concepts in Engineering Planning and Design
    1975 1.9k citations W.H. Wilson Tang et al. profile →
  4. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk
    2016 1.4k citations W.H. Wilson Tang et al. profile →
  5. Gut Microbiota in Cardiovascular Health and Disease
    2017 1.2k citations W.H. Wilson Tang et al. profile →
  6. Importance of Venous Congestion for Worsening of Renal Function in Advanced Decompensated Heart Failure
    2009 1.1k citations Wilfried Müllens, Gary S. Francis et al. Journal of the American College of Cardiology profile →
  7. Gut Microbiota-Dependent Trimethylamine N -Oxide (TMAO) Pathway Contributes to Both Development of Renal Insufficiency and Mortality Risk in Chronic Kidney Disease
    2014 955 citations W.H. Wilson Tang et al. profile →
  8. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
    2019 801 citations Wilfried Müllens, W.H. Wilson Tang et al. profile →
  9. Probability Concepts in Engineering: Emphasis on Applications to Civil and Environmental Engineering
    2006 631 citations W.H. Wilson Tang et al. profile →
  10. The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology
    2019 628 citations Wilfried Müllens, Pieter Martens et al. profile →
  11. Dietary metabolism, the gut microbiome, and heart failure
    2018 545 citations W.H. Wilson Tang et al. profile →
  12. Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure
    2014 536 citations W.H. Wilson Tang et al. Journal of the American College of Cardiology profile →
  13. The contributory role of gut microbiota in cardiovascular disease
    2014 501 citations W.H. Wilson Tang et al. profile →
  14. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors
    2020 489 citations W.H. Wilson Tang et al. profile →
  15. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide
    2014 458 citations W.H. Wilson Tang et al. profile →
  16. γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of L-Carnitine to TMAO
    2014 424 citations W.H. Wilson Tang et al. profile →
  17. Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
    2015 370 citations W.H. Wilson Tang et al. profile →
  18. Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women
    2018 348 citations W.H. Wilson Tang et al. profile →
  19. Intestinal Microbiota in Cardiovascular Health and Disease
    2019 341 citations W.H. Wilson Tang et al. Journal of the American College of Cardiology profile →
  20. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency
    2017 323 citations Gregory D. Lewis, W.H. Wilson Tang et al. profile →
  21. Machine learning prediction in cardiovascular diseases: a meta-analysis
    2020 264 citations W.H. Wilson Tang et al. profile →
  22. Deep learning for cardiovascular medicine: a practical primer
    2019 235 citations W.H. Wilson Tang et al. profile →
  23. Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of Cardiology
    2020 227 citations Wilfried Müllens, Pieter Martens et al. profile →
  24. Worsening Renal Function in Patients With Acute Heart Failure Undergoing Aggressive Diuresis Is Not Associated With Tubular Injury
    2018 208 citations W.H. Wilson Tang et al. profile →
  25. The artificial sweetener erythritol and cardiovascular event risk
    2023 115 citations W.H. Wilson Tang et al. profile →
  26. Indole-3-Propionic Acid Protects Against Heart Failure With Preserved Ejection Fraction
    2024 63 citations W.H. Wilson Tang et al. profile →
  27. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
    2024 59 citations W.H. Wilson Tang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.H. Wilson Tang United States 102 19.9k 16.5k 10.0k 7.1k 5.8k 978 50.2k
Stefan D. Anker Germany 117 27.4k 1.4× 9.2k 0.6× 13.0k 1.3× 7.5k 1.1× 7.4k 1.3× 734 56.7k
Thomas J. Wang United States 97 21.0k 1.1× 8.0k 0.5× 6.4k 0.6× 3.2k 0.5× 4.8k 0.8× 451 43.2k
Amir Lerman United States 107 27.2k 1.4× 8.0k 0.5× 7.3k 0.7× 8.3k 1.2× 15.0k 2.6× 881 51.0k
Joseph Loscalzo United States 117 10.1k 0.5× 18.0k 1.1× 11.9k 1.2× 6.7k 0.9× 6.8k 1.2× 614 55.3k
Thomas Münzel Germany 118 19.1k 1.0× 9.9k 0.6× 14.9k 1.5× 4.4k 0.6× 7.6k 1.3× 1.1k 56.1k
Martin G. Larson United States 142 53.4k 2.7× 10.0k 0.6× 10.6k 1.1× 8.0k 1.1× 12.7k 2.2× 587 89.4k
Christopher J. O’Donnell United States 94 16.7k 0.8× 6.3k 0.4× 5.4k 0.5× 3.5k 0.5× 6.9k 1.2× 332 37.7k
Christodoulos Stefanadis Greece 96 21.2k 1.1× 4.8k 0.3× 7.6k 0.8× 5.7k 0.8× 7.7k 1.3× 1.3k 46.4k
Aaron R. Folsom United States 139 26.9k 1.4× 7.2k 0.4× 8.7k 0.9× 8.4k 1.2× 11.1k 1.9× 867 75.6k
David S. Siscovick United States 107 15.0k 0.8× 4.3k 0.3× 6.4k 0.6× 4.8k 0.7× 5.8k 1.0× 598 49.9k

Countries citing papers authored by W.H. Wilson Tang

Since Specialization
Citations

This map shows the geographic impact of W.H. Wilson Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.H. Wilson Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.H. Wilson Tang more than expected).

Fields of papers citing papers by W.H. Wilson Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.H. Wilson Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.H. Wilson Tang. The network helps show where W.H. Wilson Tang may publish in the future.

Co-authorship network of co-authors of W.H. Wilson Tang

This figure shows the co-authorship network connecting the top 25 collaborators of W.H. Wilson Tang. A scholar is included among the top collaborators of W.H. Wilson Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.H. Wilson Tang. W.H. Wilson Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Milinovich, Alex, et al.. (2025). Prognostic Value of Natriuretic Peptide Levels in Heart Failure With Recovered Ejection Fraction. Circulation Heart Failure. 18(11). e013386–e013386.
3.
Zhu, Xiaolan, Peijuan Wang, W.H. Wilson Tang, et al.. (2025). Transcriptomic profiling identifies ferroptosis and NF-κB signaling involved in α-dimorphecolic acid regulation of microglial inflammation. Journal of Translational Medicine. 23(1). 260–260. 4 indexed citations
4.
Tang, W.H. Wilson, Yuxi Liu, Javed Butler, et al.. (2025). Impaired Exercise Capacity in High-Risk Diabetic Cardiomyopathy: The ARISE-HF Cardiopulmonary Exercise Testing Subanalysis. Circulation Heart Failure. 18(3). e012200–e012200. 1 indexed citations
5.
Sheikh, Farooq H., Gilbert Habib, W.H. Wilson Tang, et al.. (2025). Impact of Vutrisiran on Functional Capacity and Quality of Life in Transthyretin Amyloidosis With Cardiomyopathy. Journal of the American College of Cardiology. 85(20). 1943–1955. 3 indexed citations
6.
Hendren, Nicholas, Matthias Peltz, Maryjane Farr, et al.. (2025). Phenomapping the Response of Patients With Ischemic Cardiomyopathy With Reduced Ejection Fraction to Surgical Revascularization. Clinical Cardiology. 48(2). e70094–e70094.
7.
Kaelber, David C., et al.. (2025). Testosterone therapy in patients with heart failure and protein-calorie malnutrition: Insights from a propensity-matched cohort study. Current Problems in Cardiology. 50(7). 103070–103070. 1 indexed citations
8.
Januzzi, James L., Stefano Del Prato, Julio Rosenstock, et al.. (2024). Characterizing diabetic cardiomyopathy: baseline results from the ARISE-HF trial. Cardiovascular Diabetology. 23(1). 49–49. 12 indexed citations
9.
Tang, W.H. Wilson, Qian Peter Su, Jiayan Liao, et al.. (2023). CsPbX3 quantum Dots@ZIF-8 composites with enhanced luminescence emission and stability. Journal of Luminescence. 266. 120280–120280. 10 indexed citations
10.
Martens, Pieter, Leslie T. Cooper, & W.H. Wilson Tang. (2023). Diagnostic Approach for Suspected Acute Myocarditis: Considerations for Standardization and Broadening Clinical Spectrum. Journal of the American Heart Association. 12(17). e031454–e031454. 28 indexed citations
11.
Segar, Matthew W., Muhammad Shahzeb Khan, Kershaw V. Patel, et al.. (2023). A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure. JACC Heart Failure. 12(3). 508–520. 13 indexed citations
12.
Martens, Pieter, Gregory D. Lewis, Wilfried Müllens, & W.H. Wilson Tang. (2023). Spontaneous Improvement in Iron Parameters and the Relation With Changes in Functionality in Heart Failure. The American Journal of Cardiology. 213. 1–4. 1 indexed citations
13.
Amdani, Shahnawaz, Rocío López, Jesse D. Schold, & W.H. Wilson Tang. (2023). 30- and 60-Day Readmission Rates for Children With Heart Failure in the United States. JACC Heart Failure. 12(1). 83–96. 3 indexed citations
14.
Puri, Rishi, et al.. (2023). Aortic Valve Disease, Transcatheter Aortic Valve Replacement, and the Heart Failure Patient. JACC Heart Failure. 11(8). 1070–1083. 6 indexed citations
15.
Montgomery, Robert A., Ari Cedars, W.H. Wilson Tang, et al.. (2022). Durable Mechanical Circulatory Support in Adult Congenital Heart Disease: Reviewing Clinical Considerations and Experience. Journal of Clinical Medicine. 11(11). 3200–3200. 8 indexed citations
16.
Chaikijurajai, Thanat & W.H. Wilson Tang. (2021). Gut Microbiome and Precision Nutrition in Heart Failure: Hype or Hope?. Current Heart Failure Reports. 18(2). 23–32. 8 indexed citations
17.
Chirakarnjanakorn, Srisakul, Sankar D. Navaneethan, Gary S. Francis, & W.H. Wilson Tang. (2017). Cardiovascular impact in patients undergoing maintenance hemodialysis: Clinical management considerations. International Journal of Cardiology. 232. 12–23. 58 indexed citations
18.
Benítes-Zapata, Vicente A., Adrían V. Hernández, Vijaiganesh Nagarajan, et al.. (2014). Usefulness of Neutrophil-to-Lymphocyte Ratio in Risk Stratification of Patients With Advanced Heart Failure. The American Journal of Cardiology. 115(1). 57–61. 118 indexed citations
19.
Tang, W.H. Wilson. (2007). A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus. SHILAP Revista de lepidopterología. 1 indexed citations
20.
Tang, W.H. Wilson, Gary S. Francis, David A. Morrow, et al.. (2007). National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure. Clinical Biochemistry. 41(4-5). 210–221. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan D. Anker Breakdown of academic impact, for papers by Thomas J. Wang Breakdown of academic impact, for papers by Amir Lerman Breakdown of academic impact, for papers by Joseph Loscalzo Breakdown of academic impact, for papers by Thomas Münzel Breakdown of academic impact, for papers by Martin G. Larson Breakdown of academic impact, for papers by Christopher J. O’Donnell Breakdown of academic impact, for papers by Christodoulos Stefanadis Breakdown of academic impact, for papers by Aaron R. Folsom Breakdown of academic impact, for papers by David S. Siscovick
Rankless by CCL
2026